PTPRZ1 and breast carcinoma: The PTN-RPTPβ/ζ pathway has been also reported to affect phosphorylation and/or activation of numerous targets, such as ALK[43], Fyn and its downstream substrate beta catenin, protein kinase C (PKC) alpha or beta through inhibition of the phosphatase activity in breast cancer.